Tyrosine kinase inhibitors and immunosuppressants perturb the myo-inositol but not the betaine cotransporter in isotonic and hypertonic MDCK cells  by Atta, Mohamed G. et al.
Kidney International, Vol. 55 (1999), pp. 956–962
ION CHANNELS – MEMBRANE TRANSPORT – INTEGRATIVE PHYSIOLOGY
Tyrosine kinase inhibitors and immunosuppressants perturb
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and hypertonic MDCK cells
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Tyrosine kinase inhibitors and immunosuppressants perturb changes by activating specific metabolic and transport
the myo-inositol but not the betaine cotransporter in isotonic processes that restore cell volume to its normal resting
and hypertonic MDCK cells. state. These processes mediate the transport of inorganicBackground. The sodium/myo-inositol cotransporter (SMIT)
ions, as well as small organic molecules known as com-and the betaine cotransporter (BGT1) are essential for the
patible osmolytes [1–3]. In contrast to perturbing ions,accumulation of myo-inositol and betaine, and hence cell sur-
vival in a hypertonic environment. The underlying molecular for example, potassium and sodium, organic nonperturb-
mechanism involves an increase in transcription of the SMIT ing osmolytes have biophysical and biochemical proper-
and BGT1 genes through binding of a trans-acting factor to ties that allow cells to withstand large shifts in theirenhancer elements in the 59 flanking region of both genes, result-
concentration without deleterious effects on cellularing in increased mRNA abundance and increased activity of
structure and function [4]. Myo-inositol and betaine arethe cotransporters. Current evidence regarding transcriptional
and post-transcriptional regulation indicates that both cotrans- major organic nonperturbing osmolytes that accumulate
porters are regulated in parallel. to very high levels in hypertonic renal medulla [5]. Their
Methods. To investigate the signal transduction of hyper-
accumulation is the result of an increase in the activitytonic stress, we examined the effect of tyrosine kinase inhibitors
of their respective transporters, the Na1/myo-inositoland immunosuppressants on the hypertonicity-induced activ-
ity of the two cotransporters in Madin-Darby canine kidney cotransporter (SMIT) and the Na1,Cl2/betaine cotrans-
(MDCK) cells. porter (BGT1). The accumulation of myo-inositol and
Results. None of the agents studied affected BGT1 activity betaine in response to hypertonicity is slow and usually
in isotonic or hypertonic conditions. Treatment of MDCK cells
requires 18 to 24 hours for completion, as it results fromwith genistein, a tyrosine kinase inhibitor, increased SMIT ac-
increased transcription of the SMIT and BGT1 genestivity in hypertonic but not isotonic conditions. The stimulation
of SMIT by genistein was accompanied by a parallel increase and an increase in abundance of mRNA for the cotrans-
in mRNA abundance. In contrast, treating cells with tyrphostin porters [6, 7]. This response to hypertonicity is regulated
A23, another tyrosine kinase inhibitor, or cyclosporine A, an in part by the activation and binding of a transcriptionimmunosuppressant, inhibited SMIT activity in hypertonic cells.
factor, tonicity element-binding protein (TonEBP), toFK506, another immunosuppressant, increased SMIT activity,
enhancer elements in the 59 flanking region of the SMITbut only in isotonic conditions.
Conclusions. These results provide the first evidence of diver- and BGT1 genes [8–10]. The pathway that leads to the
gent regulatory pathways modulating SMIT and BGT activity. activation of TonEBP is not known. However, P38 ki-
nase has been shown to be activated by hypertonicity,
and its inhibition prevents the induction of BGT1 in
Constant cell volume is important for normal cell func- MDCK cells [11]. Several other protein kinases are acti-
tion and survival. Maintaining a constant cell volume dur- vated by hypertonicity as well, but their role in the accu-
ing changes in ambient tonicity (effective osmolarity) is mulation of compatible osmolytes is not clear [11, 12].
a critical problem for cells. Most cells respond to tonicity Protein tyrosine phosphorylation is part of the early hy-
pertonic signaling transduction pathway that results in
the activation of the Na1/H1 antiporter within minutesKey words: hypertonicity, cell volume, osmolytes, cotransport, protein
phosphorylation, transcription. [13, 14]. In muscle cells and fat cells, a tyrosine kinase
pathway signals the translocation of the insulin-respon-Received for publication June 26, 1998
sive glucose transporter (GLUT4) from intracellular ves-and in revised form September 30, 1998
Accepted for publication October 1, 1998 icles to the plasma membrane in response to hypertonic
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kinase C results in rapid inhibition of both the myo- 150 mm NaCl, 5 mm KCl, 2 mm CaCl2, 1.2 mm MgCl2, and
inositol and the betaine cotransporter [16]. 10 mm Tris-HEPES, pH 7.4. Hypertonic cells received
In this article, we describe the effects of tyrosine kinase uptake solution containing 200 mm raffinose. To deter-
inhibitors and of immunosuppressants on the activity of mine transporter activity, uptake was assayed at 378C in
SMIT and BGT1 in isotonic and in hypertonic cells. air by adding to each well 1 ml of uptake solution con-
Although in previous studies the activity of SMIT and taining 10 mm myo-inositol and 10 mm betaine supple-
BGT1 always behaved in a similar fashion [16–18], only mented with 0.2 mCi/ml 3H inositol and 0.04 mCi/ml 14C
SMIT activity was affected by the various agents we tested. betaine. Treatment with the agent or diluent was contin-
ued during the 20-minute uptake period. This period
represents the initial rate of the one hour linear uptake.METHODS
Uptake was ended by rinsing each well three times withGenistein, tyrphostin A23, and epidermal growth fac-
ice-cold stop solution (160 mm choline chloride, 10 mmtor (EGF) were purchased from CalBiochem (La Jolla,
Tris-HEPES, pH 7.4). In hypertonic cells, uptake wasCA, USA). Genistin was purchased from Sigma Chemi-
ended with ice-cold stop solution containing 200 mmcal Co. (St. Louis, MO, USA). Cyclosporins and FK506
raffinose. Cells were extracted overnight at room temper-were gifts from Dr. William Briggs (Division of Nephrol-
ature by the addition of 1 ml of 0.25 m sodium hydroxideogy, Johns Hopkins University School of Medicine, Bal-
to each well. Extracts were neutralized with 1 m hydro-timore, MD, USA). 3H-myo-inositol and 32P dCTP were
chloric acid (62.5 ml HCl for 250 ml of extract) and as-purchased from Amersham Life Science (Arlington
sayed for 3H, 14C, and protein concentration (proteinHeights, IL, USA), and 14C-betaine was purchased from
assay kit; Bio-Rad Laboratories, Hercules, CA, USA).American Radiolabeled Chemicals, Inc. (St. Louis, MO,
Madin-Darby canine kidney cells were exposed to var-USA). Coon’s modified F12 medium was purchased from
ious amounts of each agent to determine optimal concen-Irvine Scientific (Santa Ana, CA, USA), and Dulbecco’s
trations. One-hundred mm genistein, 100 mm tyrphostin,modified Eagle’s medium was from Mediatech, Inc.
(Herndon, VA, USA). 100 ng/ml EGF, and 3 mm cyclosporine were associated
with significant cell death likely caused by prolonged
Cell culture exposure. Therefore, only concentrations with no effect
Madin-Darby canine kidney cells obtained from the on protein yield were used in subsequent experiments.
American Type Culture Collection (Rockville, MD, USA) Epidermal growth factor, genistein, and tyrphostin
were studied in passages 20 to 30 after arrival in our lab. were prepared as 20 ng/ml, 5.4 mg/ml, and 3.8 mg/ml stock
Cells were grown as previously described [19] in a serum- solutions in distilled water, 100% ethanol, and dimethyl
free defined medium, a 50:50 mixture of Dulbecco’s mod- sulfoxide, respectively. Following dilution, the total con-
ified Eagle’s medium with 1 g/liter d-glucose and Coon’s centration of these diluents in the culture medium was
modified F-12 medium containing 10 mm N-2-hydroxy- 0.15%. Cyclosporine was prepared as 0.5 mg/ml stock solu-
ethylpiperazine-N9-2-ethanesulfonic acid (HEPES), pH tion in 100% ethanol. Following dilution, the total con-
7.5, 5 pm triiodothyronine, 50 nm hydrocortisone, 10 nm centration of ethanol in the culture medium was 0.24%.
Na2SeO3, 5 mg/ml transferrin, 5 mg/ml insulin, 25 ng/ml FK506 was prepared as 1 mg/ml stock solution in phos-
prostaglandin E1, 2 mm l-glutamine, 100 IU/ml penicillin, phate-buffered saline (PBS). Following dilution, the total
and 100 mg/ml streptomycin. The medium contained 119
concentration of PBS in the culture medium was 0.082%.
mm myo-inositol but lacks betaine. Where appropriate,
We also examined whether the change in activity of thethe medium was made hypertonic by the addition of 200
cotransporters was the result of a short-term exposure tomm raffinose.
the agents. When MDCK cells were incubated in isotonic
or hypertonic medium for 18 to 22 hours and then exposedTransport studies
for 30 minutes to genistein, tyrphostin, cyclosporine, orCells were grown to confluence in six-well cluster
FK506 just before uptake was assayed, there was nodishes (Becton Dickinson Labware, Franklin Lakes, NJ,
effect on SMIT or BGT1 activity (data not shown), indi-USA). Three wells received the test agent, and three
cating that the effects in shown in Figures 1 and 2 aftercontrol wells received diluent. The experiments began
prolonged treatment with these agents were not the re-with a 30-minute exposure to the test agent or its diluent
sult of short-term effects on the cotransporters. Definedin isotonic medium. The medium was then changed to
medium contains myo-inositol but not betaine. Whenisotonic or hypertonic medium containing the same
100 mm betaine was added to the culture medium, how-agent or diluent and incubated overnight. At the end of
ever, the effect of 30 mm genistein, 30 ng/ml EGF, or 1 mm18 to 22 hours, each well was rinsed twice with uptake
cyclosporin on the transporters activity was unchangedsolution, a buffer devoid of all osmolytes to remove myo-
inositol present in the medium. The uptake solution was (data not shown).
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Fig. 1. (A) Effect of epidermal growth factor (EGF) and various inhibi-
tors on sodium/myo-inositol cotransporter (SMIT) and the betaine co-
transporter (BGT1) activity in Madin-Darby canine kidney (MDCK)
cells in isotonic medium. The medium contained the vehicle or the test
agent (30 mm genistein, N 5 7; 30 ng/ml EGF, N 5 8; 30 ng/ml EGF
plus 30 mm genistein, N 5 5; 30 mm tyrphostin A23, N 5 5; 30 ng/ml Fig. 2. (A) Effect of each agent on SMIT activity relative to that on
EGF plus 30 mm tyrphostin A23, N 5 5; 1 mm cyclosporine, N 5 5; or BGT1 activity in isotonic medium. *P values of , 0.05 comparing the
1 mm FK506, N 5 5). Incubation was 20 hours. The percent changes in action of each agent on SMIT activity to that on BGT1 are shown. (B)
SMIT activity (h) and BGT1 activity ( ) are shown. Results are the Effect of each agent on SMIT activity relative to that on BGT1 activity
mean 6 se. *P values of , 0.05 comparing the action of each agent on in hypertonic medium. *P values of , 0.05 are shown. The effect of
SMIT or BGT1 activity to control are shown. (B) Effect of EGF and cyclosporine approached but did not reach statistical significance (P 5
various inhibitors on SMIT and BGT1 activity in MDCK cells in hyper- 0.068).
tonic medium. The symbols and concentrations are the same as in (A).
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Northern analysis hypertonic cells. When we tested the effect of simultane-
ous addition of genistein and EGF, the increase in SMITConfluent MDCK cells in isotonic or hypertonic me-
activity in isotonic cells, presumably the effect of EGF,dium were treated with 30 mm genistein or diluent (alco-
was still evident, as was the increase in SMIT in hyper-hol) for 18 hours. Total RNA was extracted with Trizol
tonic cells, presumably the effect of genistein (Fig. 1).(Life Technologies, Inc., Gaithersburg, MD, USA). For
The results in isotonic cells suggest that genistein is notNorthern analysis, RNA (10 mg per lane) was separated
acting by inhibiting tyrosine kinase activity of the EGFon a 1% agarose formaldehyde gel and transferred over-
receptor (or that EGF is acting via a genistein insensitivenight to a nitrocellulose membrane (Schleicher & Schuell,
receptor). Although further studies are required to de-Keene, NH, USA). The blot was ultraviolet cross-linked
fine the site of action of EGF and genistein in theseand cut just above the 28S marker. Hybridization of the
experiments, it is noteworthy that only the activity ofupper part of the blot was carried out at 658C overnight
SMIT was affected. The data are presented in Figure 2with canine SMIT cDNA probe [19]. The lower part of
as a ratio of the effect on SMIT to that on BGT1.the blot was separately hybridized with canine betaine
To further examine the role of tyrosine kinases incotransporter (BGT1) cDNA probe [20] under the same
the regulation of SMIT and BGT1, we tested anotherconditions. The blots were washed twice with 2 3 SSC
tyrosine kinase inhibitor, tyrphostin A23. Like genistein,(0.15 m sodium chloride and 0.15 m sodium citrate) con-
overnight treatment with 30 mm tyrphostin A23 had notaining 0.1% sodium dodecyl sulfate at room tempera-
effect on the activity of SMIT or BGT1 in isotonic cellsture for five minutes and once with 0.5 3 SSC containing
(Fig. 1A). In hypertonic cells, however, incubation with0.1% sodium dodecyl sulfate at 658C for 30 minutes.
tyrphostin A23 inhibited the activity of SMIT by 20%Radioactivity was detected by Phosphorimage analysis
(Fig. 1B). BGT1 activity in the same cells was not af-(Molecular Dynamics, Sunnyvale, CA, USA).
fected (Fig. 1B). The selective effect on SMIT activity
Statistics relative to that on BGT1 activity is shown in Figure 2B.
As with genistein, the effect of tyrphostin A23 on SMITThe analysis of the extracts was performed in duplicate
activity was evident in hypertonic cells simultaneouslyfor each well, and the mean uptake in three experimental
treated with 30 mm tyrphostin A23 and 30 ng/ml EGFor control wells was considered as a single experiment.
(Fig. 1B). However, unlike that seen in the presence ofResults are expressed in pmol/minute/mg protein. Statis-
genistein, the effect of EGF on SMIT activity was notical analyses for isotonic and hypertonic conditions were
longer significant in isotonic cells (Fig. 1A). Althoughperformed by comparing the effect of each agent on SMIT
tyrphostin A23 in the presence of EGF decreased BGT1and BGT1 to their paired controls using one-sample two-
activity by 11%, the effect on SMIT relative to that ontailed t-tests. Comparing the effect of each agent on
BGT1 remained significant (Fig. 2B).SMIT with that on BGT1 was done using the Wilcoxon
signed-rank test.
Immunosuppressants
Tonicity element-binding protein, the transcription
RESULTS factor that mediates the stimulation of transcription of
Transport studies SMIT and BGT1, shares sequence similarity with the
NF-AT family of transcription factors (unpublished ob-Tyrosine kinase inhibitors. As previously reported,
servation). Because the immunosuppressants cyclosporinovernight exposure of MDCK cells to hypertonic me-
and FK506 inhibit calcineurin, which is involved in thedium resulted in an approximately fivefold increase in
activation of NF-AT transcription factors, the effects ofthe activity of SMIT and BGT1 [17, 18]. Overnight treat-
these agents on SMIT and BGT1 activity were deter-ment with 30 mm genistein had no effect on the activity
mined. One mm cyclosporin inhibited SMIT activity inof either transporter in isotonic cells (Fig. 1A). In hyper-
hypertonic cells without affecting BGT1 activity (Fig.tonic cells, genistein increased the activity of SMIT by
1B). There was no effect on either transporter in isotonic47% (Fig. 1B). Overnight treatment with genistin, an
cells (Fig. 1A). When isotonic MDCK cells were treatedinactive form of genistein [21], had no effect on SMIT
with 1 mm FK506, the activities of SMIT and BGT1or BGT1 activity in isotonic or hypertonic conditions.
were increased (Fig. 1A). However, the change in BGT1Because genistein is a recognized inhibitor of receptor
activity was small, only 7%. As seen with the previoustyrosine kinases, particularly epidermal growth factor
agents, the effect of FK506 on SMIT activity relative toreceptor (EGFR) tyrosine kinase, we tested the effect
that on BGT1 activity in isotonic cells was significantlyof EGF on SMIT and BGT1. Isotonic cells treated with
greater than unity (Fig. 2A). FK506 had no effect on30 ng/ml EGF showed a 30% increase in SMIT activity
hypertonic cells. Because cyclosporine and FK506 didand little effect on BGT1 activity (Fig. 1A). Epidermal
growth factor had no effect on SMIT or BGT1 activity in not have the same effect on cotransporter activity, it is
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The striking sensitivity of SMIT to the various inhibi-
tors in contrast to the minimal or no effect on BGT1
raises the question of whether SMIT was affected be-
cause its substrate myo-inositol was present in the me-
dium throughout the prolonged incubation with the in-
hibitors, whereas the substrate for BGT1, betaine, was
not. To answer this question, we repeated the experiments
that showed the most striking divergence in effect on
the two cotransporters (genistein, EGF, and cyclosporin)
using a defined medium, which is betaine free or a me-
dium supplemented with 100 mm betaine, similar to the
concentration of myo-inositol in the medium. The results
in both sets of experiments were similar (data not
shown). Only the activity of SMIT was affected, as in
Figure 1, despite the presence of betaine throughout the
incubation.
DISCUSSION
The most striking finding in this study is the divergent
effect of each agent on SMIT and BGT1 activity. Al-
though transcription has been shown to be a major step
that leads to the accumulation of organic osmolytes inFig. 3. Northern blot analysis of MDCK cells cultured in isotonic (I)
or hypertonic (H) medium without (control) or with 30 mM genistein response to hypertonicity, it is evident that the regulation
for 18 hours. Radioactive bands representing SMIT (9.5 kb) and BGT1 is complex and subject to perturbation by a number of
(large band—actually a doublet of 3.4 and 2.9 kb obscured by the 28s
factors. Although protein kinases are activated rapidlyRNA) mRNA are indicated.
by hypertonicity [13, 14], the role of protein phosphoryla-
tion in the regulation of organic osmolyte accumulation,
a late response to hypertonicity, has not been extensively
unlikely that their effects are due to the inhibition of studied. In contrast to the sole effect of a variety of
calcineurin. agents on SMIT activity in this study, it was previously
shown that activation of protein kinase A or protein
Northern analysis kinase C inhibits the activity of SMIT and BGT1 after
The largest effect observed was with genistein treat- 30 minutes [16]. The agents used in this study had no
ment. To examine whether the genistein induced changes effect in that period (data not shown).
in SMIT activity are associated with changes in mRNA Genistein is recognized as a receptor protein tyrosine
abundance, Northern blot analysis was performed on kinase (PTK) inhibitor, particularly EGF receptor tyro-
RNA prepared from MDCK cells treated for 18 hours sine kinase, with little effect on other protein kinases,
with 30 mm genistein using SMIT and BGT1 cDNA phosphatases, or phosphodiesterases [22–26]. In this
probes. Treatment with 30 mm genistein increased SMIT study, prolonged (20 hour) incubation with genistein
mRNA in hypertonic cells (Fig. 3). To focus on the effect stimulated the hypertonic response of SMIT without elic-
of genistein on SMIT mRNA relative to that on BGT1 iting change in the BGT1 response. Genistein did not
mRNA, we used BGT1 mRNA as a control for loading alter the activity of either transporter in isotonic cells.
because there was no effect of genistein on BGT1 activity The lack of effect of genistein on BGT1 suggests that a
in the uptake studies (Fig. 1B). This was performed by PTK or some other genistein-sensitive step is involved
separately hybridizing the lower part of a single blot with in the regulation of SMIT activity but not BGT1 activity
a canine BGT1 cDNA probe and the upper part with a in hypertonic cells. Genistein may act by inhibiting phos-
canine SMIT probe. In parallel with the uptake data, phorylation of SMIT. More likely, especially in view of
genistein significantly increased SMIT mRNA by 39% the prolonged exposure to genistein in these experiments,
in three independent experiments. In contrast to gen- it is possible that genistein inhibits the phosphorylation
istein, we were unable to detect differences in mRNA of other proteins, which subsequently results in increased
abundance with other agents. This may be a reflection SMIT activity. The parallel increase in SMIT activity
of smaller changes in mRNA abundance as well as in and mRNA abundance suggests that genistein affects
SMIT activity with these agents, or it may indicate that SMIT regulation at the level of transcription in hyper-
tonic cells. The lack of an effect on SMIT transcriptionthe effects of the other agents are post-transcriptional.
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